Replies to post #212003 on Biotech Values

[DewDiligence]

PSDV/ALIM rework partnership for Durasert and Iluvien:

https://globenewswire.com/news-release/2017/07/10/1042213/0/en/pSivida-Out-licenses-EMEA-Rights-for-Durasert-Three-year-Treatment-for-Posterior-Segment-Uveitis-While-Retaining-U-S-Commercial-Rights-Amended-Global-Collaboration-Agreement-with-A.html